by Nabaparna Bhattacharya | Nov 22, 2024 | News
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) saw its shares rise on Friday in the premarket session. Today, the company announced results from a Dose Range Finding (DRF) study for Probudur, its long-acting liposomal bupivacaine formulation. The study, conducted in...
Recent Comments